Management 1x1 Series: James Lanthier, CEO of Mindset Pharma - The Future of Psychedelics

Grizzle Pod: Thematic Growth Investing

内容由Grizzle提供。所有播客内容（包括剧集、图形和播客描述）均由 Grizzle 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

2y ago 28:32

M4A•单集首页

In our second episode of the Management 1x1 Series we are thrilled to have James Lanthier, CEO of Mindset Pharma join us. Mindset is one of the world's leading companies in the field of psychedelic medicines to treat neurological and psychiatric disorders. James brings a wealth of insight to the pod and breaks down the big picture of the true disruption happening in the psychedelics industry - enjoy the interview.

Segments:

0:40 What's the opportunity set and how disruptive are psychedelics?

4:58 Where are we in terms of cultural and medical acceptance of psychedelics?

9:26 Mindset Pharma's science driven focus in the sector

13:42 Understanding the process of enhancing 1st generation psychedelic drugs.

18:45 Mindset's partnership with big pharma - Otsuka Pharmaceuticals, understanding the validation and importance for the industry.

23:40 The asset light nature of the business model.

25:13 The outlook for the psychedelics industry and what separates winners from losers?

92集单集

#Trading #Business #Grizzle